The Latin America, Middle East and Africa Cardiovascular Digital Solutions Market should witness market growth of 11.1% CAGR during the forecast period (2022-2028).
One of the biggest issues facing healthcare professionals is providing patients with CVDs with the best practice care. Management of CVDs must be frequent, ongoing, and seamless. In order to help patients, their families, and communities manage and improve their health, digital technologies will continue to be implemented with a focus on these diseases. This will be done by raising standards of care, expanding access to equity, boosting efficiency, and encouraging better patient self-management.
Digital solutions have been developed totreat, manage, and prevent a condition. Itrepresents a digital health solution that delivers medicinal interventions directly to patients. Such solutions typically use software or technologies that are evidence-based and clinically proven to collect real-time patient information and offer a better therapeutic response. Digital solutionshave drawn a lot of interest from both investors and industry stakeholders because of the continuous digitization efforts and modernization of the healthcare sector. Additionally, government agencies have taken active steps to establish regulations, publish laws, and implement legislation in the field of digital therapies.
In the Latin American region, the Argentine government has additionally established an interoperability centerwhere all parties (public and commercial) can collaborate to produce synergies that ought to result in better patient results. In Brazil, the COVID-19 outbreak catalyzed the creation of digital health policies. The establishment of genuine governing entities (like the National Health Data Network - Rede Nacional de Dados em Sade) in preparation for implementing a significant data-driven healthcare plan incorporating technology has beennoted as one of the main projects. Brazilian experts believe that this disruption has the potential to significantly alter how healthcare is organized and delivered in the region. Hence, the significant initiatives taking place in the region to promote the delivery of healthcare are the major factors accelerating the expansion of the cardiovascular digital solution market in the region.
The Brazil market dominated the LAMEA Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,721.9 Million by 2028. The Argentina market is experiencing a CAGR of 11.7% during (2022-2028). Additionally, The UAE market would display a CAGR of 10.8% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
One of the biggest issues facing healthcare professionals is providing patients with CVDs with the best practice care. Management of CVDs must be frequent, ongoing, and seamless. In order to help patients, their families, and communities manage and improve their health, digital technologies will continue to be implemented with a focus on these diseases. This will be done by raising standards of care, expanding access to equity, boosting efficiency, and encouraging better patient self-management.
Digital solutions have been developed totreat, manage, and prevent a condition. Itrepresents a digital health solution that delivers medicinal interventions directly to patients. Such solutions typically use software or technologies that are evidence-based and clinically proven to collect real-time patient information and offer a better therapeutic response. Digital solutionshave drawn a lot of interest from both investors and industry stakeholders because of the continuous digitization efforts and modernization of the healthcare sector. Additionally, government agencies have taken active steps to establish regulations, publish laws, and implement legislation in the field of digital therapies.
In the Latin American region, the Argentine government has additionally established an interoperability centerwhere all parties (public and commercial) can collaborate to produce synergies that ought to result in better patient results. In Brazil, the COVID-19 outbreak catalyzed the creation of digital health policies. The establishment of genuine governing entities (like the National Health Data Network - Rede Nacional de Dados em Sade) in preparation for implementing a significant data-driven healthcare plan incorporating technology has beennoted as one of the main projects. Brazilian experts believe that this disruption has the potential to significantly alter how healthcare is organized and delivered in the region. Hence, the significant initiatives taking place in the region to promote the delivery of healthcare are the major factors accelerating the expansion of the cardiovascular digital solution market in the region.
The Brazil market dominated the LAMEA Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,721.9 Million by 2028. The Argentina market is experiencing a CAGR of 11.7% during (2022-2028). Additionally, The UAE market would display a CAGR of 10.8% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Scope of the Study
By Service Type
- Unobtrusive Testing
- CVD Health Informatics
- Cardiac Rehab Programs
- Others
By End-use
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
By Deployment
- Cloud-Based
- On-premise
By Components
- Devices
- Software
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cardiovascular Digital Solutions Market, by Service Type
1.4.2 LAMEA Cardiovascular Digital Solutions Market, by End-use
1.4.3 LAMEA Cardiovascular Digital Solutions Market, by Deployment
1.4.4 LAMEA Cardiovascular Digital Solutions Market, by Components
1.4.5 LAMEA Cardiovascular Digital Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players
Chapter 4. LAMEA Cardiovascular Digital Solutions Market by Service Type
4.1 LAMEA Unobtrusive Testing Market by Country
4.2 LAMEA CVD Health Informatics Market by Country
4.3 LAMEA Cardiac Rehab Programs Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA Cardiovascular Digital Solutions Market by End-use
5.1 LAMEA Hospitals & Clinics Market by Country
5.2 LAMEA Ambulatory Care Centers Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Cardiovascular Digital Solutions Market by Deployment
6.1 LAMEA Cloud-Based Market by Country
6.2 LAMEA On-premise Market by Country
Chapter 7. LAMEA Cardiovascular Digital Solutions Market by Components
7.1 LAMEA Devices Market by Country
7.2 LAMEA Software Market by Country
Chapter 8. LAMEA Cardiovascular Digital Solutions Market by Country
8.1 Brazil Cardiovascular Digital Solutions Market
8.1.1 Brazil Cardiovascular Digital Solutions Market by Service Type
8.1.2 Brazil Cardiovascular Digital Solutions Market by End-use
8.1.3 Brazil Cardiovascular Digital Solutions Market by Deployment
8.1.4 Brazil Cardiovascular Digital Solutions Market by Components
8.2 Argentina Cardiovascular Digital Solutions Market
8.2.1 Argentina Cardiovascular Digital Solutions Market by Service Type
8.2.2 Argentina Cardiovascular Digital Solutions Market by End-use
8.2.3 Argentina Cardiovascular Digital Solutions Market by Deployment
8.2.4 Argentina Cardiovascular Digital Solutions Market by Components
8.3 UAE Cardiovascular Digital Solutions Market
8.3.1 UAE Cardiovascular Digital Solutions Market by Service Type
8.3.2 UAE Cardiovascular Digital Solutions Market by End-use
8.3.3 UAE Cardiovascular Digital Solutions Market by Deployment
8.3.4 UAE Cardiovascular Digital Solutions Market by Components
8.4 Saudi Arabia Cardiovascular Digital Solutions Market
8.4.1 Saudi Arabia Cardiovascular Digital Solutions Market by Service Type
8.4.2 Saudi Arabia Cardiovascular Digital Solutions Market by End-use
8.4.3 Saudi Arabia Cardiovascular Digital Solutions Market by Deployment
8.4.4 Saudi Arabia Cardiovascular Digital Solutions Market by Components
8.5 South Africa Cardiovascular Digital Solutions Market
8.5.1 South Africa Cardiovascular Digital Solutions Market by Service Type
8.5.2 South Africa Cardiovascular Digital Solutions Market by End-use
8.5.3 South Africa Cardiovascular Digital Solutions Market by Deployment
8.5.4 South Africa Cardiovascular Digital Solutions Market by Components
8.6 Nigeria Cardiovascular Digital Solutions Market
8.6.1 Nigeria Cardiovascular Digital Solutions Market by Service Type
8.6.2 Nigeria Cardiovascular Digital Solutions Market by End-use
8.6.3 Nigeria Cardiovascular Digital Solutions Market by Deployment
8.6.4 Nigeria Cardiovascular Digital Solutions Market by Components
8.7 Rest of LAMEA Cardiovascular Digital Solutions Market
8.7.1 Rest of LAMEA Cardiovascular Digital Solutions Market by Service Type
8.7.2 Rest of LAMEA Cardiovascular Digital Solutions Market by End-use
8.7.3 Rest of LAMEA Cardiovascular Digital Solutions Market by Deployment
8.7.4 Rest of LAMEA Cardiovascular Digital Solutions Market by Components
Chapter 9. Company Profiles
9.1 Apple, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 General Electric Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Koninklijke Philips N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Verily Life Sciences LLC (Alphabet, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 iRhythm Technologies, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.8 AliveCor, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.8.2.2 Product Launches and Product Expansions:
9.9 Cardiotrack
9.9.1 Company Overview
9.10. HeartFlow, Inc.
9.10.1 Company Overview
Companies Mentioned
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Methodology
LOADING...
